Novel immunotherapy vaccine decreases recurrence in HER2 positive breast cancer patients
(University of Texas M. D. Anderson Cancer Center) A new breast cancer vaccine candidate, GP2, provides further evidence of the potential of immunotherapy in preventing disease recurrence.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | HER2 | Texas University | Vaccines